Detalhe da pesquisa
1.
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
Biol Blood Marrow Transplant
; 24(2): 373-380, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051021
2.
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(4): 710-716, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475726
3.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
Biol Blood Marrow Transplant
; 21(3): 389-401.e1, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25529383
4.
Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.
Haematologica
; 99(10): 1618-23, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997150
5.
Clinical benefit of response in chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 18(10): 1517-24, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22683612
6.
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 18(11): 1649-55, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22691695
7.
Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients.
Blood Adv
; 3(18): 2764-2777, 2019 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31551243
8.
Recognizing and managing chronic graft-versus-host disease.
Hematology Am Soc Hematol Educ Program
; : 134-41, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074071
9.
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
Biol Blood Marrow Transplant
; 12(4): 375-96, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16545722
10.
Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 12(7): 792-4, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16785070
11.
Carcinoma de células escamosas em língua pós-transplante de medula óssea por Anemia de Fanconi / Squamous cell carcinoma of the tongue due to Fanconi's Anemia after bone marrow transplantation
Rev. bras. hematol. hemoter
; 25(4): 239-246, out.-dez. 2003.
Artigo
em Português
| LILACS | ID: lil-359495